Arch Biopartners (TSXV:ARCH) 3-Year EBITDA Growth Rate : 13.40% (As of Dec. 2023)

View and export this data going back to 2000. Start your Free Trial

What is Arch Biopartners 3-Year EBITDA Growth Rate?

Arch Biopartners's EBITDA per Share for the three months ended in Dec. 2023 was C$-0.01.

During the past 3 years, the average EBITDA Per Share Growth Rate was 13.40% per year. During the past 5 years, the average EBITDA Per Share Growth Rate was 10.60% per year. During the past 10 years, the average EBITDA Per Share Growth Rate was -18.00% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

During the past 13 years, the highest 3-Year average EBITDA Per Share Growth Rate of Arch Biopartners was 64.00% per year. The lowest was -68.10% per year. And the median was -4.75% per year.

Competitive Comparison of Arch Biopartners's 3-Year EBITDA Growth Rate

For the Biotechnology subindustry, Arch Biopartners's 3-Year EBITDA Growth Rate, along with its competitors' market caps and 3-Year EBITDA Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Arch Biopartners's 3-Year EBITDA Growth Rate Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Arch Biopartners's 3-Year EBITDA Growth Rate distribution charts can be found below:

* The bar in red indicates where Arch Biopartners's 3-Year EBITDA Growth Rate falls into.

Arch Biopartners 3-Year EBITDA Growth Rate Calculation

This is the 3-year average growth rate of EBITDA per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

Arch Biopartners (TSXV:ARCH) 3-Year EBITDA Growth Rate Explanation

EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.

Arch Biopartners 3-Year EBITDA Growth Rate Related Terms

Thank you for viewing the detailed overview of Arch Biopartners's 3-Year EBITDA Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

Arch Biopartners (TSXV:ARCH) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Arch Biopartners Inc (TSXV:ARCH) » Definitions » 3-Year EBITDA Growth Rate

Comparable Companies

Traded in Other Exchanges

N/A

Address

545 King Street West, Toronto, ON, CAN, M5V 1M1

Website

https://www.archbiopartners.com

Arch Biopartners Inc is a clinical stage company developing technologies with the potential to make medical or commercial impacts. The company is developing a drug platform Metablok to produce drug candidates to inhibit organ inflammation caused via the DPEP-1 pathway. It's under development portfolio is AB569, a potential new treatment for antibiotic resistant bacterial infections in the lungs or wounds; and, Borg peptide coatings that increase corrosion resistance and decrease bacterial biofilm on various medical grade metals and plastics.